188 related articles for article (PubMed ID: 19845827)
21. Crosstalk of hypoxia-mediated signaling pathways in upregulating plasminogen activator inhibitor-1 expression in keloid fibroblasts.
Zhang Q; Wu Y; Chau CH; Ann DK; Bertolami CN; Le AD
J Cell Physiol; 2004 Apr; 199(1):89-97. PubMed ID: 14978738
[TBL] [Abstract][Full Text] [Related]
22. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
Fernández-Ruiz J; Romero J; Ramos JA
Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
[TBL] [Abstract][Full Text] [Related]
23. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor-1: Regulatory mechanisms and drug development in stroke.
Pan Z; Ma G; Kong L; Du G
Pharmacol Res; 2021 Aug; 170():105742. PubMed ID: 34182129
[TBL] [Abstract][Full Text] [Related]
25. Role of protein kinase Cdelta in transmitting hypoxia signal to HSF and HIF-1.
Baek SH; Lee UY; Park EM; Han MY; Lee YS; Park YM
J Cell Physiol; 2001 Aug; 188(2):223-35. PubMed ID: 11424089
[TBL] [Abstract][Full Text] [Related]
26. The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain.
Trollmann R; Gassmann M
Brain Dev; 2009 Aug; 31(7):503-9. PubMed ID: 19398180
[TBL] [Abstract][Full Text] [Related]
27. Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway.
Lee E; Yim S; Lee SK; Park H
Mol Cells; 2002 Aug; 14(1):9-15. PubMed ID: 12243358
[TBL] [Abstract][Full Text] [Related]
28. Regulation of HIF: asparaginyl hydroxylation.
Peet D; Linke S
Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
[TBL] [Abstract][Full Text] [Related]
29. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
30. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration.
Wang L; Ankati H; Akubathini SK; Balderamos M; Storey CA; Patel AV; Price V; Kretzschmar D; Biehl ER; D'Mello SR
J Neurosci Res; 2010 Jul; 88(9):1970-84. PubMed ID: 20143421
[TBL] [Abstract][Full Text] [Related]
32. The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury.
Fan X; Heijnen CJ; van der Kooij MA; Groenendaal F; van Bel F
Brain Res Rev; 2009 Dec; 62(1):99-108. PubMed ID: 19786048
[TBL] [Abstract][Full Text] [Related]
33. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
34. Fighting neurodegeneration with rapamycin: mechanistic insights.
Bové J; Martínez-Vicente M; Vila M
Nat Rev Neurosci; 2011 Jul; 12(8):437-52. PubMed ID: 21772323
[TBL] [Abstract][Full Text] [Related]
35. Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection.
Harten SK; Ashcroft M; Maxwell PH
Antioxid Redox Signal; 2010 Apr; 12(4):459-80. PubMed ID: 19737089
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
[TBL] [Abstract][Full Text] [Related]
37. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
38. The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).
Ozer A; Wu LC; Bruick RK
Proc Natl Acad Sci U S A; 2005 May; 102(21):7481-6. PubMed ID: 15897452
[TBL] [Abstract][Full Text] [Related]
39. Targeting hypoxia-inducible factor 1 (HIF-1) signaling with natural products toward cancer chemotherapy.
Ikeda H; Kakeya H
J Antibiot (Tokyo); 2021 Oct; 74(10):687-695. PubMed ID: 34331027
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
